sb 203580 has been researched along with gw 4869 in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (gw 4869) | Trials (gw 4869) | Recent Studies (post-2010) (gw 4869) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 137 | 0 | 125 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Forman, SP; Katzenberg, G; Ohanian, J; Ohanian, V | 1 |
1 other study(ies) available for sb 203580 and gw 4869
Article | Year |
---|---|
Endothelin-1 stimulates small artery VCAM-1 expression through p38MAPK-dependent neutral sphingomyelinase.
Topics: Aniline Compounds; Animals; Benzylidene Compounds; Endothelin B Receptor Antagonists; Endothelin-1; HSP27 Heat-Shock Proteins; Imidazoles; Mesenteric Arteries; Oligopeptides; p38 Mitogen-Activated Protein Kinases; Peptides, Cyclic; Piperidines; Pyridines; Rats; Sphingomyelin Phosphodiesterase; Vascular Cell Adhesion Molecule-1 | 2012 |